WO2006004774A3 - Laulimalide analogues as therapeutic agents - Google Patents
Laulimalide analogues as therapeutic agents Download PDFInfo
- Publication number
- WO2006004774A3 WO2006004774A3 PCT/US2005/022965 US2005022965W WO2006004774A3 WO 2006004774 A3 WO2006004774 A3 WO 2006004774A3 US 2005022965 W US2005022965 W US 2005022965W WO 2006004774 A3 WO2006004774 A3 WO 2006004774A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- laulimalide
- analogues
- therapeutic agents
- compounds
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/630,858 US20080280973A1 (en) | 2004-06-28 | 2005-06-28 | Laulimalide Analogues as Therapeutic Agents |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58391504P | 2004-06-28 | 2004-06-28 | |
US60/583,915 | 2004-06-28 | ||
US61458804P | 2004-09-30 | 2004-09-30 | |
US60/614,588 | 2004-09-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006004774A2 WO2006004774A2 (en) | 2006-01-12 |
WO2006004774A3 true WO2006004774A3 (en) | 2006-08-24 |
Family
ID=35783323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/022965 WO2006004774A2 (en) | 2004-06-28 | 2005-06-28 | Laulimalide analogues as therapeutic agents |
Country Status (2)
Country | Link |
---|---|
US (1) | US20080280973A1 (en) |
WO (1) | WO2006004774A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090099252A1 (en) * | 2007-08-10 | 2009-04-16 | Wender Paul A | Novel laulimalide analogues as therapeutic agents |
CA2838401C (en) | 2011-06-06 | 2021-01-12 | The Board Of Regents Of The University Of Texas System | Taccalonolide microtubule stabilizers |
EP3554509A4 (en) * | 2016-12-15 | 2020-11-11 | The Board of Regents of The University of Texas System | Taccalonolide microtubule stabilizers |
CN110368717B (en) * | 2019-05-30 | 2021-10-15 | 郑州大学 | Polylactic acid non-woven filter cloth material for oil/water separation and preparation method thereof |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
US4522811A (en) * | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US4530840A (en) * | 1982-07-29 | 1985-07-23 | The Stolle Research And Development Corporation | Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents |
US4906474A (en) * | 1983-03-22 | 1990-03-06 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
US4725442A (en) * | 1983-06-17 | 1988-02-16 | Haynes Duncan H | Microdroplets of water-insoluble drugs and injectable formulations containing same |
US4622219A (en) * | 1983-06-17 | 1986-11-11 | Haynes Duncan H | Method of inducing local anesthesia using microdroplets of a general anesthetic |
US5364620A (en) * | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
US4891225A (en) * | 1984-05-21 | 1990-01-02 | Massachusetts Institute Of Technology | Bioerodible polyanhydrides for controlled drug delivery |
IT1198449B (en) * | 1986-10-13 | 1988-12-21 | F I D I Farmaceutici Italiani | ESTERS OF POLYVALENT ALCOHOLS OF HYALURONIC ACID |
US5718921A (en) * | 1987-03-13 | 1998-02-17 | Massachusetts Institute Of Technology | Microspheres comprising polymer and drug dispersed there within |
US4769234A (en) * | 1987-10-06 | 1988-09-06 | Peter M. Stephan Center Ltd. | Skin care compositions containing polyvalent equine immune serum |
IE60383B1 (en) * | 1988-05-27 | 1994-07-13 | Elan Corp Plc | Controlled release pharmaceutical formulation |
US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
US5356630A (en) * | 1989-02-22 | 1994-10-18 | Massachusetts Institute Of Technology | Delivery system for controlled release of bioactive factors |
IE66933B1 (en) * | 1990-01-15 | 1996-02-07 | Elan Corp Plc | Controlled absorption naproxen formulation for once-daily administration |
IE82916B1 (en) * | 1990-11-02 | 2003-06-11 | Elan Corp Plc | Formulations and their use in the treatment of neurological diseases |
US5149543A (en) * | 1990-10-05 | 1992-09-22 | Massachusetts Institute Of Technology | Ionically cross-linked polymeric microcapsules |
US5626863A (en) * | 1992-02-28 | 1997-05-06 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US6515009B1 (en) * | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
AU664214B2 (en) * | 1991-11-13 | 1995-11-09 | Elan Corporation, Plc | Drug delivery device |
US5260068A (en) * | 1992-05-04 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Multiparticulate pulsatile drug delivery system |
US5260069A (en) * | 1992-11-27 | 1993-11-09 | Anda Sr Pharmaceuticals Inc. | Pulsatile particles drug delivery system |
US5744449A (en) * | 1993-05-10 | 1998-04-28 | Lipps; Binie V. | Lethal toxin neutralizing factors |
US5716981A (en) * | 1993-07-19 | 1998-02-10 | Angiogenesis Technologies, Inc. | Anti-angiogenic compositions and methods of use |
DK0797988T3 (en) * | 1993-07-19 | 2009-05-11 | Univ British Columbia | Anti-angiogenic compositions and methods for their use |
US5565215A (en) * | 1993-07-23 | 1996-10-15 | Massachusettes Institute Of Technology | Biodegradable injectable particles for imaging |
EP1118325B2 (en) * | 1993-07-29 | 2010-01-06 | The United States of America, represented by the Secretary, Department of Health and Human Services | Use of Paclitaxel and its derivatives in the manufacture of a medicament for treating restenosis. |
US5419917A (en) * | 1994-02-14 | 1995-05-30 | Andrx Pharmaceuticals, Inc. | Controlled release hydrogel formulation |
US5458888A (en) * | 1994-03-02 | 1995-10-17 | Andrx Pharmaceuticals, Inc. | Controlled release tablet formulation |
US5728402A (en) * | 1994-11-16 | 1998-03-17 | Andrx Pharmaceuticals Inc. | Controlled release formulation of captopril or a prodrug of captopril |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
IE75744B1 (en) * | 1995-04-03 | 1997-09-24 | Elan Corp Plc | Controlled release biodegradable micro- and nanospheres containing cyclosporin |
IE80468B1 (en) * | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
US5736159A (en) * | 1995-04-28 | 1998-04-07 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water insoluble drugs in which a passageway is formed in situ |
US5558879A (en) * | 1995-04-28 | 1996-09-24 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water soluble drugs in which a passageway is formed in situ |
US6273913B1 (en) * | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6414015B1 (en) * | 2000-01-28 | 2002-07-02 | Utah State University | Laulimalide microtubule stabilizing agents |
WO2002064589A1 (en) * | 2001-02-09 | 2002-08-22 | Kosan Biosciences, Inc. | Laulimalide derivatives |
AU2003216491A1 (en) * | 2002-03-07 | 2003-09-22 | The Board Of Trustees Of The University Of Illinois | Microtubule stabilizing compounds |
-
2005
- 2005-06-28 WO PCT/US2005/022965 patent/WO2006004774A2/en active Application Filing
- 2005-06-28 US US11/630,858 patent/US20080280973A1/en not_active Abandoned
Non-Patent Citations (2)
Title |
---|
ANDERTON ET AL.: "Structural features of borrelidin, an antiviral antibiotic", NATURE, vol. 206, 1965, pages 265, XP008070527 * |
RAPHAEL R.A. ET AL.: "The self-condensation of cycloDecane-1:2-dione", JOURNAL OF THE CHEMICAL SOCIETY, 1952, XP008070534 * |
Also Published As
Publication number | Publication date |
---|---|
US20080280973A1 (en) | 2008-11-13 |
WO2006004774A2 (en) | 2006-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX349188B (en) | Sns-595 and methods of using the same. | |
WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
WO2006017295A3 (en) | Tetrapeptide analogs | |
MXPA05008406A (en) | Phenylacetamides and their use as glucokinase modulators. | |
WO2005116088A3 (en) | Methods and compositions for treating diseases and disorders associated with siglec-8 expressing cells | |
WO2006023649A3 (en) | Treatment of severe multiple sclerosis | |
WO2003101444A8 (en) | Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer | |
WO2006004703A3 (en) | PYRROLO[2,3-d]PYRIMIDINES THAT MODULATE ACK1 AND LCK ACTIVITY | |
WO2005049000A3 (en) | Treatment of phenylketonurias with bh4 | |
WO2006055871A3 (en) | Treatment for multiple sclerosis | |
WO2007047608A3 (en) | Fibrin targeted therapeutics | |
MXPA05004697A (en) | Pharmaceutical solutions comprising a modafinil compound and their use for the manufacture of a medicament for treating different diseases. | |
WO2001079164A3 (en) | N-substituted dithiocarbamates for the treatment of biological disorders | |
WO2006102375A3 (en) | Methods for avoiding edema in the treatment or prevention of pparϝ-responsive diseases, including cancer | |
WO2007130501A3 (en) | Combination therapy for treatment of cancer | |
WO2004043379A3 (en) | Chemical compounds | |
WO2004069160A3 (en) | Chemical compounds | |
WO2004004653A3 (en) | Methods for treating psychosis associated with interferon-alpha therapy | |
HK1102626A1 (en) | Compositions and methods for the treatment and prevention of hyperproliferative diseases | |
WO2006004774A3 (en) | Laulimalide analogues as therapeutic agents | |
UA83821C2 (en) | Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain | |
WO2003076445A3 (en) | Microtubule stabilizing compounds | |
HK1074840A1 (en) | Novel dithiolopyrrolones with therapeutic activity | |
WO2004080477A8 (en) | Aplidine for multiple myeloma treatment | |
AU2003255843A1 (en) | 1,3-thiazolin-4-ones as therapeutic compounds in the treatment of pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005768179 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11630858 Country of ref document: US |